REVB Q3 2025 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$6,765

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-1.77

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$874

Balance Sheet

Total Assets

$13M

Total Liabilities

$2M

Stockholders' Equity

$11M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6,765	-$7,220	+6.3%
Operating Income	-$2M	-$2M	-8.1%
Net Income	-$2M	-$2M	+14.9%